Immunotherapy toxicities: less common and rare side-effects, nurse-led assessment and management

Published Caitlin Broomhall on

This webinar was designed for nurses seeking to expand their knowledge of less common and rare side-effects of immunotherapy in melanoma treatment. While some immunotherapy toxicities are common but manageable, less common and rare side-effects can create additional complexities. This session explored immunotherapy toxicities and presented case studies of less common and rare side-effects, discussing implications for nurses in assessment and management, and gave nurses insights into nurse-led approaches to potentially serious or life-threatening side-effects.

Watch on demand

Event recording

Recording guide

Explore the topics

Open the guide below to see the seven topics covered, then select any topic to open the recording at that point on YouTube in a new tab.

Show the 7 topicsHide the topics

Learning outcomes

What you will learn

After this session, nurses will be able to:

01

Recognise the spectrum of toxicities

Recognise the spectrum of immunotherapy toxicities.

02

Differentiate serious and life-threatening effects

Differentiate between less common but serious and rare but potentially life-threatening side effects.

03

Nursing approaches to assessment and management

Discuss nursing approaches in assessing and managing less common and rare side effects.

04

Patient education tools and language

Equip nurses with tools and language to educate patients on recognising and reporting symptoms.

At a glance

The event in brief

Originally held

Thursday 17 July 2025

Online webinar, part of the Melanoma Nursing Webinar Program.

Who this is for

Nurses

Nurses seeking to expand their knowledge of less common and rare side-effects of immunotherapy in melanoma treatment.

Contributors

Speakers

Alethea Lobo

Speaker

Alethea Lobo

Melanoma Clinical Nurse Consultant, Peter MacCallum Cancer Centre; Co-chair, Melanoma and Skin Cancer Nurses Organisation

Alethea has extensive experience in caring for patients with all stages of melanoma, with a particular focus on the identification and management of treatment toxicities. Alethea is passionate about raising awareness of melanoma and other skin cancers amongst nurses so together they can better support patients.

Donna Milne

Speaker

Donna Milne

Clinical Nurse Consultant, Melanoma and Skin Cancer Service, Peter MacCallum Cancer Centre

Donna's main areas of interest include management of immunotherapy and targeted therapy toxicities and supporting and educating patients with advanced cancer and their carers. Donna's PhD examined the perceptions of palliative care held by patients with advanced cancer. She was a founding co-chair of MSCNO, the Melanoma and Skin Cancer Nurses Organisation, and has a Life Fellowship with CNSA.

This webinar was brought to you by

Melanoma Institute Logo

Resource details

Heading
Course type
Webinars
Duration
60 mins
Price
$0.00
Curriculum Area
Treatment (incl. Supportive Care)
Monitoring and Surveillance
Speciality
Clinician
Nurse
Cancer therapy
Clinical care
Immunotherapy
Melanoma
Nursing
Skin cancers

This course is brought to you by

Alliance members